[An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy]. (Record no. 25356193)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01494 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517055925.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201511s 0 0 jpn d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0385-0684 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Mouri, Atsuto |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20151116 |
245 00 - TITLE STATEMENT | |
Title | [An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy]. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Gan to kagaku ryoho. Cancer & chemotherapy |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1091-3 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antimetabolites, Antineoplastic |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Combinations |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fatal Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gefitinib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxonic Acid |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinazolines |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Salvage Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tegafur |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hamamoto, Yoichiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kameyama, Nobuhisa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ibe, Tatsuya |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Takeoka, Shinjiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Honma, Chie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fukusumi, Munehisa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kamimura, Mitsuhiro |
773 0# - HOST ITEM ENTRY | |
Title | Gan to kagaku ryoho. Cancer & chemotherapy |
Related parts | vol. 42 |
-- | no. 9 |
-- | p. 1091-3 |
No items available.